Effect of Drug Therapy on Net Cholesterol Efflux Capacity of High-Density Lipoprotein-Enriched Serum in Rheumatoid Arthritis.
about
Spotlight on sirukumab for the treatment of rheumatoid arthritis: the evidence to dateHDL cholesterol efflux capacity in rheumatoid arthritis patients: contributing factors and relationship with subclinical atherosclerosis.Lipids in RA: Is Less Not Necessarily More?The Impact of Biologics and Tofacitinib on Cardiovascular Risk Factors and Outcomes in Patients with Rheumatic Disease: A Systematic Literature Review.Net cholesterol efflux capacity of HDL enriched serum and coronary atherosclerosis in rheumatoid arthritis.Repurposing existing drugs for cardiovascular risk management: a focus on methotrexate
P2860
Effect of Drug Therapy on Net Cholesterol Efflux Capacity of High-Density Lipoprotein-Enriched Serum in Rheumatoid Arthritis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Effect of Drug Therapy on Net ...... Serum in Rheumatoid Arthritis.
@en
type
label
Effect of Drug Therapy on Net ...... Serum in Rheumatoid Arthritis.
@en
prefLabel
Effect of Drug Therapy on Net ...... Serum in Rheumatoid Arthritis.
@en
P2093
P2860
P356
P1476
Effect of Drug Therapy on Net ...... Serum in Rheumatoid Arthritis.
@en
P2093
C Michael Stein
Jeffrey R Curtis
Joseph F Solus
Kasey C Vickers
L Jackson Roberts
MacRae F Linton
Michelle J Ormseth
Patricia G Yancey
S Louis Bridges
Sean S Davies
P2860
P304
P356
10.1002/ART.39675
P577
2016-03-18T00:00:00Z